Back to Treatments

Treatment

Mineralocorticoid Receptor Antagonists (Spironolactone)

1
Conditions
10
Trials
15K
Participants
70%
Average Safety

Condition Evidence

Heart Failure

10 trials · 15K participants

77% effectiveness · 70% safety
Mineralocorticoid Receptor Antagonists (Spironolactone) | DFDA